Navigation Links
Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results
Date:8/11/2009

About Vion

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative oncology therapeutics. Vion has two agents in clinical trials, Onrigin (laromustine) Injection and Triapine((R)). The Company has an NDA under review with the FDA for Onrigin for remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML). Triapine((R)), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, particularly Onrigin (laromustine) Injection, delays in the regulatory approval process, particularly for Onrigin (laromustine) Injection, including possible delays in the FDA's review process beyond our expectation for approval in December 2009, delays or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies, clinical trials or interim clinical trial data are not confirmed by safety and efficacy results in later or final clinical trials, the need for additional research and testing, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations or to enter into strategic partnership agreements, the inability to access capital and funding on favorable terms, continued operating losses an
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... World Gardens Café, the premier provider ... cuisine, received rave reviews last week when it gave ... attendees were amazed that healthy food could taste so ... Café, the premier provider of delicious and flavorful home-delivered ... Dave Linden’s LA’s Largest Mixer. Attendees who stopped by ...
(Date:7/23/2014)... Sanuvox has produced a six minute ... company’s latest system designed for hospital surface disinfection. ... a primary and secondary unit to eliminate shadows ... controlling (6 log reduction) drug-resistant microorganisms such as ... minutes in a standard patient hospital room. The ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Low ... state-run insurance exchanges to come up with alternative ... of the myriad ways to accomplish this in ... Inside Health Insurance Exchanges (HEX). , “We never ... for state-run exchanges, Christopher Condeluci, an attorney at ...
(Date:7/23/2014)... MA (PRWEB) July 23, 2014 ... medical education to a community of more than 260,000 ... Medicine Ultrasound Institute will launch a national continuing medical ... care clinicians about new advancements in ultrasound and how ... Pri-Med and the University of South Carolina School of ...
(Date:7/23/2014)... 23, 2014 TeraGanix has recently ... Grande, Arizona, located only 4.5 miles off of highway I-8. ... convenience and accessibility for businesses in the Arizona region that ... crops. , Its Casa Grande location is only 1 hour ... one hour from Phoenix. With over 26 million acres ...
Breaking Medicine News(10 mins):Health News:Healthy Food Gets Rave Reviews at LA’s Largest Mixer 2Health News:Sanuvox Produces ASEPTIX² Movie Showcasing the Feature Benefits of the Company’s Latest Flagship Hospital Surface Disinfection System 2Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 2Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 3Health News:Pri-Med and the University of South Carolina School of Medicine Launch National Ultrasound Education Initiative for Primary Care Clinicians 2Health News:Pri-Med and the University of South Carolina School of Medicine Launch National Ultrasound Education Initiative for Primary Care Clinicians 3Health News:TeraGanix Opens New Arizona-Based Agricultural Products Supply Facility 2Health News:TeraGanix Opens New Arizona-Based Agricultural Products Supply Facility 3
... in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine ... jetlag in passengers by nearly 50 percent. The two-part ... scoring system, showed Pycnogenol lowered symptoms of jetlag such ... both healthy individuals and hypertensive patients. Passengers also experienced ...
... Ignagni, President,and CEO of America,s Health Insurance Plans ... Obama:, "We congratulate President-elect Barack Obama for ... for health care reform, and we look forward ... Congress to develop,workable solutions to the health care ...
... found , , WEDNESDAY, Nov. 5 (HealthDay News) -- Researchers ... to eliminate memory problems in mice with the rodent ... no way to know if the treatment will have ... enroll Alzheimer,s patients in a new study, and scientists ...
... 5 The American,Nurses Association (ANA) congratulates President-Elect ... to working with the new administration,and new lawmakers ... patients we,serve., President-Elect Barack Obama has been ... state senator, and as a U.S. Senator,Barack Obama ...
... 5 & 1 Plan, OWINGS MILLS, Md., Nov. ... portion-controlled weight-loss program, today,announced the launch of its newest ... formula that is lower in calories, total fat, and,carbohydrates. ... Crunch, and Caramel Crunch, and are available at, http://www.choosemedifast.com/ ...
... look forward to health system reform in 2009, ... Nancy Nielsen, M.D., AMA President:, "The American Medical ... the presidency of the United States. He has,proposed a ... made it a,central issue in his campaign., "The ...
Cached Medicine News:Health News:Study shows pine bark reduces jetlag 2Health News:Study shows pine bark reduces jetlag 3Health News:Vitamin Holds Promise for Alzheimer's Disease 2Health News:Medifast Adds New Crunchy Bars to Product Line 2Health News:AMA Congratulates President-Elect Obama 2
(Date:7/23/2014)... July 23, 2014 Research and ... "Emulsifiers - Global Strategic Business Report" ... http://photos.prnewswire.com/prnh/20130307/600769 This report analyzes ... and US$ Thousands by the following Product Segments: ... Polysorbates and Sorbitan Esters, and Polyglycin Polyricinoleate & ...
(Date:7/22/2014)... 2014 /PRNewswire-iReach/ -- The global digital X-ray market ... portability, product, end user, price, and geography. The ... growth rate in the digital X-ray market by ... is attributed to technological advancements and the rising ... the largest share of the digital X-ray market, ...
(Date:7/22/2014)... July 22, 2014 The National Space Biomedical ... Center for Space Radiation Research (CSRR) under the leadership ... an Associate Professor of Pharmaceutical Sciences within the University ... Division of Radiation Health. She is located in ... a team of investigators working across four U.S. institutions, ...
Breaking Medicine Technology:Emulsifiers - Global Strategic Business Report: Updated 2014 Report 2Emulsifiers - Global Strategic Business Report: Updated 2014 Report 3Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 2Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 3Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 4Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 5Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 3
... A new skin cancer drug tested for the first time ... Piper Cancer Center at Scottsdale Healthcare just received expedited approval ... in new drug development. (Photo: http://photos.prnewswire.com/prnh/20120201/DC45876 ) ... time in the world Jan. 23, 2007 in a phase ...
... growth rate for psychiatric medication spending has declined significantly, ... Thomson Reuters (Healthcare) and the Substance Abuse and Mental ... ) The paper, which appears in ... Services , underlines falling prices of psychiatric medications as ...
Cached Medicine Technology:FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen 2FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen 3Psychiatric Medication Spending Growth Slows, According to New Thomson Reuters Research 2Psychiatric Medication Spending Growth Slows, According to New Thomson Reuters Research 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: